Akari Therapeutics Mutual Funds

Health Care & Life Sciences » Biotechnology | Akari Therapeutics PLC

Akari Therapeutics PLC ADR | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

SG Actions Monde Techno

23,200

0.15%

0.05%

01/31/2018

Trust for Professional Managers - PMC Diversified Equity Fund

8,316

0.06%

05/31/2018

RIM Global - CC Bioscience

-1,400

06/30/2017

View Profile

Address	75/76 Wimpole Street London London & South East W1G 9RT United Kingdom
Employees	-
Website	http://akaritx.com
Updated	07/08/2019
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Coversin, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.